Mühleder et al., 2018 - Google Patents
The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cellsMühleder et al., 2018
View HTML- Document ID
- 149284014802067445
- Author
- Mühleder S
- Pill K
- Schaupper M
- Labuda K
- Priglinger E
- Hofbauer P
- Charwat V
- Marx U
- Redl H
- Holnthoner W
- Publication year
- Publication venue
- Stem cell research & therapy
External Links
Snippet
Background Co-cultures of endothelial cells with mesenchymal stem cells currently represent one of the most promising approaches in providing oxygen and nutrient supply for microvascular tissue engineering. Still, to translate this model into clinics several in vitro …
- 230000002792 vascular 0 title abstract description 70
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mühleder et al. | The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells | |
Piard et al. | 3D printed HUVECs/MSCs cocultures impact cellular interactions and angiogenesis depending on cell-cell distance | |
Kachgal et al. | Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms | |
Ahmann et al. | Fibrin degradation enhances vascular smooth muscle cell proliferation and matrix deposition in fibrin-based tissue constructs fabricated in vitro | |
Fortunato et al. | Platelet lysate gel and endothelial progenitors stimulate microvascular network formation in vitro: tissue engineering implications | |
Rohringer et al. | Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells | |
Ehrbar et al. | Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity | |
Vorwald et al. | Tunable fibrin-alginate interpenetrating network hydrogels to support cell spreading and network formation | |
Peters et al. | Poly (ethylene glycol) hydrogel scaffolds containing cell-adhesive and protease-sensitive peptides support microvessel formation by endothelial progenitor cells | |
Anitua et al. | Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties | |
Tanaka et al. | Preparation of fibrin hydrogels to promote the recruitment of anti-inflammatory macrophages | |
Natesan et al. | A bilayer construct controls adipose-derived stem cell differentiation into endothelial cells and pericytes without growth factor stimulation | |
Holnthoner et al. | Adipose‐derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix | |
Duffy et al. | Towards in vitro vascularisation of collagen-GAG scaffolds | |
Lin et al. | Three-dimensional topography of synthetic scaffolds induces elastin synthesis by human coronary artery smooth muscle cells | |
Bidarra et al. | Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery | |
Kayabolen et al. | Native extracellular matrix/fibroin hydrogels for adipose tissue engineering with enhanced vascularization | |
Hutton et al. | Platelet-derived growth factor and spatiotemporal cues induce development of vascularized bone tissue by adipose-derived stem cells | |
Cerqueira et al. | Cell sheet technology-driven re-epithelialization and neovascularization of skin wounds | |
Liu et al. | Vasculogenic and osteogenesis-enhancing potential of human umbilical cord blood endothelial colony-forming cells | |
Lienemann et al. | Smart hydrogels for the augmentation of bone regeneration by endogenous mesenchymal progenitor cell recruitment | |
Heltmann-Meyer et al. | Gelatin methacryloyl is a slow degrading material allowing vascularization and long-term use in vivo | |
Smith Jr et al. | Capture of endothelial cells under flow using immobilized vascular endothelial growth factor | |
Nishi et al. | Engineered bone tissue associated with vascularization utilizing a rotating wall vessel bioreactor | |
Krawiec et al. | In vivo functional evaluation of tissue-engineered vascular grafts fabricated using human adipose-derived stem cells from high cardiovascular risk populations |